(NYSE: AORT) Artivion's forecast annual revenue growth rate of 12.29% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.5%.
Artivion's revenue in 2026 is $441,330,000.On average, 9 Wall Street analysts forecast AORT's revenue for 2026 to be $24,134,441,766, with the lowest AORT revenue forecast at $22,806,142,463, and the highest AORT revenue forecast at $24,956,608,277. On average, 9 Wall Street analysts forecast AORT's revenue for 2027 to be $26,829,826,328, with the lowest AORT revenue forecast at $25,105,527,197, and the highest AORT revenue forecast at $28,004,418,321.
In 2028, AORT is forecast to generate $30,093,592,748 in revenue, with the lowest revenue forecast at $28,676,708,235 and the highest revenue forecast at $31,232,750,657.